O2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19
February 25 2021 - 9:00AM
O2TODAY ("O2TODAY"), a mask company that develops, manufactures and
commercializes face masks for medical and non-medical uses, and
SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”)
(www.sintx.com), an original equipment manufacturer (OEM) of
silicon nitride ceramics, announced today they have entered into a
worldwide exclusive licensing agreement.
O2TODAY expects to release their first consumer
mask integrated with SINTX’s silicon nitride during 2021. The mask
will inactivate pathogens in the fabric itself, therefore reducing
the spread of viral diseases and effectively fighting against
COVID-19. Since the outbreak of COVID-19, SINTX Technologies has
been testing the antiviral properties of silicon nitride for use in
antipathogenic applications. Rigorous safety, efficacy, and
wearability tests are currently underway.
O2TODAY and SINTX entered a collaboration during
2020 shortly after the COVID-19 pandemic was underway. The newly
announced and signed Technology License Agreement is a 2-year
engagement, with an option for extension. The agreement includes a
license fee, a commercial agreement on silicon nitride sales, and
royalties based upon product sales of the masks and filters.
“We are thrilled to enter this agreement with
SINTX Technologies, a company that has a remarkable history of
conducting the science and developing products based on silicon
nitride and its various formulations,” said Bruce Lorange, CEO of
O2TODAY. “We are passionate about respiratory health, and have been
an innovator in the design, and manufacturing of protective face
wear that reduces exposure to airborne threats since 2015. We
believe that this agreement will position O2TODAY as a market
leader in the next generation of face masks to combat COVID-19 and
other air-borne ailments caused by viruses and bacteria.”
“The development of a catch-and-kill mask
containing SINTX’s silicon nitride is an important step towards
offering viral protection to healthcare professionals and the
general public,” said Dr. Sonny Bal, CEO and President of SINTX
Technologies. “Given the effectiveness of silicon nitride in
inactivating pathogens, there is an opportunity to turn what has
been single-use masks into a reusable PPE, thereby extending their
life for healthcare workers and essential personnel.”
O2TODAY products are distributed through airport
and travel retailers, direct-to-consumer, enterprise, and
healthcare channels. COVID-19 has boosted the market demand for
respiratory and surgical masks with overall shipments estimated to
reach over 10 billion units by 2025. Beyond COVID-19, there is a
global need for respiratory hygiene, and the global reusable mask
market is expected to continue growing. In addition to
disease-causing viruses and bacteria, particulate pollution, dust,
and smoke, and respiratory diseases are a reality in many
countries, including the U.S.
To control the supply chain from raw material to
finished goods, and to meet the global demand for face masks driven
by COVID-19, O2TODAY established a new production facility in Salt
Lake City, close to SINTX’s manufacturing plant. O2TODAY produces a
range of products including surgical and N95 health care respirator
masks, as well as replacement filters for its line of reusable face
masks.
About O2TODAY
O2TODAY (www.O2TODAY.com) is a privately-held
company with its headquarters located in Salt Lake City, Utah. Even
before the COVID-19 pandemic, O2TODAY designed and manufactured its
proprietary face mask technology that helps reduce exposure to
health threats resulting from respiratory droplets, pathogens,
allergens, dust, wildfire haze, and other forms of PM 2.5
particulate pollution. As a member of 1% For The Planet, O2TODAY
supports organizations driving initiatives to combat air pollution,
the leading environmental health threat on the planet, and
promoting public health through education of the medical risks
resulting from harmful air quality.
For more information on O2TODAY or its products, please
visit www.O2TODAY.com.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company
that develops and commercializes silicon nitride for medical and
non-medical applications. The core strength of SINTX Technologies
is the manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride powders and components in its FDA registered and
ISO 13485:2016 certified manufacturing facility.
For more information on SINTX Technologies or its silicon
nitride material platform, please visit www.sintx.com.
Forward-Looking Statements
SINTX Technologies: This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 (PSLRA) that are subject
to a number of risks and uncertainties. Risks and uncertainties
that may cause such differences include, among other things,
SINTX’s ability to complete its obligations under the agreement;
the collaboration with O2TODAY may not result in the development of
any products; that SINTX has not as yet developed any products with
antiviral properties which incorporate the use of silicon nitride;
products developed under the joint development agreement may not be
effective against the SARS-CoV-2 virus; incorporation of silicon
nitride into personal protective equipment may not be safe or
effective; volatility in the price of SINTX’s common stock; the
uncertainties inherent in new product development, including the
cost and time required to commercialize such product(s); market
acceptance of our products once commercialized; SINTX’s ability to
raise additional funding and other competitive developments.
Readers are cautioned not to place undue reliance on the
forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or
at all due to certain risks and uncertainties, a discussion of
which can be found in SINTX’s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange
Commission (SEC) on March 26, 2020, and in SINTX’s other filings
with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business Inquiries for SINTX: SINTX
Technologies 801.839.3502 IR@sintx.com
Media Inquiries for SINTX: Amanda Barry
Associate Director, Content and PR The Summit
Groupabarry@summitslc.com
Business Inquiries for O2TODAY: O2TODAY
info@o2today.com
- O2TODAY & SINTX Technologies, Inc.
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Aug 2024 to Sep 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Sep 2023 to Sep 2024